Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I N Bruce

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
The Pharmacogenomics Journal|March 28, 2012
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patientsS A Owen, S L Hider, P Martin, et al.
Annals of the Rheumatic Diseases|May 26, 1999
Factors associated with fatigue in patients with systemic lupus erythematosusI N Bruce, V C Mak, D C Hallett, et al.
Annals of the Rheumatic Diseases|September 8, 2007
Environmental risk factors for the development of psoriatic arthritis: results from a case-control studyE Pattison, B J Harrison, C E M Griffiths, et al.
The Journal of Rheumatology|February 11, 1999
The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugsP Rahman, D D Gladman, M B Urowitz, et al.
Rheumatology (Oxford, England)|June 10, 2008
Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTXS L Hider, W Thomson, L F Mack, et al.
Lupus|September 7, 2011
An analysis of the metabolic syndrome phenotype in systemic lupus erythematosusB Parker, Y Ahmad, J Shelmerdine, et al.
The Pharmacogenomics Journal|September 21, 2011
MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphismsS A Owen, M Lunt, J Bowes, et al.
Annals of the Rheumatic Diseases|December 14, 2002
Contribution of patient related differences to multidrug resistance in rheumatoid arthritisC Morgan, M Lunt, H Brightwell, et al.
Annals of the Rheumatic Diseases|March 1, 2006
Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drugS L Hider, A Owen, R Hartkoorn, et al.
Scandinavian Journal of Rheumatology|January 1, 1997
Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitisI N Bruce, C M Harris, A Nugent, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
The Pharmacogenomics Journal|March 28, 2012
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patientsS A Owen, S L Hider, P Martin, et al.
Annals of the Rheumatic Diseases|May 26, 1999
Factors associated with fatigue in patients with systemic lupus erythematosusI N Bruce, V C Mak, D C Hallett, et al.
Annals of the Rheumatic Diseases|September 8, 2007
Environmental risk factors for the development of psoriatic arthritis: results from a case-control studyE Pattison, B J Harrison, C E M Griffiths, et al.
The Journal of Rheumatology|February 11, 1999
The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugsP Rahman, D D Gladman, M B Urowitz, et al.
Rheumatology (Oxford, England)|June 10, 2008
Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTXS L Hider, W Thomson, L F Mack, et al.
Lupus|September 7, 2011
An analysis of the metabolic syndrome phenotype in systemic lupus erythematosusB Parker, Y Ahmad, J Shelmerdine, et al.
The Pharmacogenomics Journal|September 21, 2011
MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphismsS A Owen, M Lunt, J Bowes, et al.
Annals of the Rheumatic Diseases|December 14, 2002
Contribution of patient related differences to multidrug resistance in rheumatoid arthritisC Morgan, M Lunt, H Brightwell, et al.
Annals of the Rheumatic Diseases|March 1, 2006
Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drugS L Hider, A Owen, R Hartkoorn, et al.
Scandinavian Journal of Rheumatology|January 1, 1997
Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitisI N Bruce, C M Harris, A Nugent, et al.
Pageof 7